Evidence map›Paper›PMID 29897225›Full record

ArticleACS applied materials & interfaces2018

Establishment of a Human iPSC- and Nanofiber-Based Microphysiological Blood-Brain Barrier System.

Dianjun Qi, Shaohua Wu, Haishuang Lin, Mitchell A Kuss, Yuguo Lei, Alexey Krasnoslobodtsev, Shaheen Ahmed, Chi Zhang, Hyung Joon Kim, Peng Jiang and 1 more

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 57 citations in OpenAlex.

  1. HumanBioactive materials · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Astrocytes and human artificial blood-brain barrier models.Bosnian journal of basic medical sciences · 2022
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Towards organoid culture without Matrigel.Communications biology · 2021
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Dianjun QiDepartment of General Practice , The First Affiliated Hospital of China Medical University , Shenyang , Liaoning 110001 , China.
Shaohua WuCollege of Textiles & Clothing , Qingdao University , Qingdao 266071 , China.
Haishuang LinDepartment of Chemical and Biomolecular Engineering , University of Nebraska-Lincoln , Lincoln , Nebraska 68588 , United States.
Mitchell A Kuss
Yuguo LeiDepartment of Chemical and Biomolecular Engineering , University of Nebraska-Lincoln , Lincoln , Nebraska 68588 , United States.ORCID http://orcid.org/0000-0002-7682-6912
Alexey KrasnoslobodtsevDepartment of Physics , University of Nebraska at Omaha , Omaha , Nebraska 68182 , United States.
Shaheen Ahmed
Chi Zhang
Hyung Joon Kim
Peng JiangDepartment of Cell Biology and Neuroscience , Rutgers University , Piscataway , New Jersey 08854 , United States.
University of Nebraska Medical Center · USUniversity of Nebraska–Lincoln · USFirst Hospital of China Medical University · CNQingdao University · CNRutgers, The State University of New Jersey · USUniversity of Nebraska at Omaha · US

Funding

UNMC/EPPLEY CANCER CENTER SUPPORT GRANTP30CA036727 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Joann B. Sweasy · 1985 to 2026
$55.0M
Research Pilot Project ProgramP30GM106397 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI JOHNSON, KEITH R · 2013 to 2017
$4.9M
Novel Functions of OLIG2 in Regulating Human Interneuron Production in Health and DiseaseR01NS102382 · NINDS · RUTGERS, THE STATE UNIV OF N.J. · PI JIANG, PENG · 2018 to 2022
$1.6M
Developing an Astroglial Model for Down SyndromeR21HD091512 · NICHD · RUTGERS, THE STATE UNIV OF N.J. · PI JIANG, PENG · 2017 to 2018
$426k
NCI NIH HHS P30 CA036727NICHD NIH HHS R21 HD091512NIGMS NIH HHS P30 GM106397NINDS NIH HHS R01 NS102382
6 · The paper itself

Abstract

The blood-brain barrier (BBB) is an active and complex diffusion barrier that separates the circulating blood from the brain and extracellular fluid, regulates nutrient transportation, and provides protection against various toxic compounds and pathogens. Creating an in vitro microphysiological BBB system, particularly with relevant human cell types, will significantly facilitate the research of neuropharmaceutical drug delivery, screening, and transport, as well as improve our understanding of pathologies that are due to BBB damage. Currently, most of the in vitro BBB models are generated by culturing rodent astrocytes and endothelial cells, using commercially available transwell membranes. Those membranes are made of plastic biopolymers that are nonbiodegradable, porous, and stiff. In addition, distinct from rodent astrocytes, human astrocytes possess unique cell complexity and physiology, which are among the few characteristics that differentiate human brains from rodent brains. In this study, we established a novel human BBB microphysiologocal system, consisting of a three-dimensionally printed holder with a electrospun poly(lactic- co-glycolic) acid (PLGA) nanofibrous mesh, a bilayer coculture of human astrocytes, and endothelial cells, derived from human induced pluripotent stem cells (hiPSCs), on the electrospun PLGA mesh. This human BBB model achieved significant barrier integrity with tight junction protein expression, an effective permeability to sodium fluorescein, and higher transendothelial electrical resistance (TEER) comparing to electrospun mesh-based counterparts. Moreover, the coculture of hiPSC-derived astrocytes and endothielial cells promoted the tight junction protein expression and the TEER value. We further verified the barrier functions of our BBB model with antibrain tumor drugs (paclitaxel and bortezomib) and a neurotoxic peptide (amyloid β 1-42). The human microphysiological system generated in this study will potentially provide a new, powerful tool for research on human BBB physiology and pathology.

Indexed as

Induced Pluripotent Stem CellsAmyloid beta-PeptidesAstrocytesBlood-Brain BarrierCells, CulturedCoculture TechniquesHumansNanofibersAmyloid beta-Peptides3D printingdrug screeningelectrospinninghuman induced pluripotent stem cellstransepithelial electrical resistance

Identifiers

PMID29897225
PMCPMC6052796
OpenAlexW2808278622

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.